Javier Martínez

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Bipolar Disorder

Hyaluronic Acid

Top Venues

Neuropsychiatric disease and treatment

Drug design, development and therapy

NPJ schizophrenia

Laboratorios Farmacéuticos ROVI

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Laboratorios Farmacéuticos ROVI

Spain

Medical Director :: Medical Dpt.

Publications

Robert Litman, Dieter Naber, Lourdes Anta, Javier Martínez, Yuriy Filts, Christoph U Correll
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM. Neuropsychiatric disease and treatment 19 (2023)
Robert Litman, Dieter Naber, Lourdes Anta, Javier Martínez, Yuriy Filts, Christoph U Correll
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM. Neuropsychiatric disease and treatment 19 (2023)
David P Walling, Howard A Hassman, Lourdes Anta, Lourdes Ochoa, Ignacio Ayani, Javier Martínez, Ibon Gutierro
The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study. Drug design, development and therapy 15 (2021)
Christoph U Correll, Robert E Litman, Yuriy Filts, Jordi Llaudó, Dieter Naber, Ferràn Torres, Javier Martínez
Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation. NPJ schizophrenia 6 (1) (2020)